Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALPN | ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | $36.6M | Jul 15, 2022 | ||
ELTX | Elicio Therapeutics, Inc. | Director | $501K | +$998K | Nov 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|